Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Neuropharmacology of Paroxetine
1
x
$
30.00
Psychopharmacology Bulletin VOL 49 No. 2, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
1
x
$
30.00
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
1
x
$
30.00
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
1
x
$
30.00
View Cart
Checkout
Home
antidepressant agents
“Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
$
30.00
Add to cart
Details
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 4, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Page load link
Go to Top
